1 Room. 20 Programs. 100% Medicare Eligible.

DTC EXCLUSIVE BUNDLE

The DM-Flow (Separate) our three (3) devices offer five (5) tests and have seven (7) eligible billing codes are both non-invasive diagnostic tools used in Primary Care, Endocrinology, Cardiology, and Podiatry clinics to assess vascularization, vascular function, and autonomic nervous system performance. They provide healthcare providers with insights into a patient’s risk for cardiovascular disease, peripheral arterial disease (PAD), and autonomic dysfunctions, including sudomotor dysfunction and loss of sensation—often associated with conditions such as diabetes, hypertension, and metabolic syndrome.

DTC EXCLUSIVE: Our 5 tests and seven (7) eligible billing codes (ABI2 /ANS/SFT/LOPS) bundle aids in the early detection and management of diabetes, cardiovascular, and metabolic conditions.

The DM-Flow (separate): 7 Billing Codes

The DM-Flow is a state-of-the-art diagnostic systems designed to revolutionize patient care by providing a comprehensive and integrated approach to health assessments. Composed of five (5) assessments, the platform offers a seamless blend of cutting-edge technology and clinical precision, enabling healthcare providers to assess and monitor critical health parameters efficiently and effectively.

All of the assessments work together to deliver a holistic view of a patient’s health, focusing on vascular function, autonomic nervous system performance, and other vital metrics, ensuring that no aspect of patient care is overlooked. This innovative system empowers clinicians to detect early signs of chronic conditions, track disease progression, and implement preventive strategies tailored to each patient, ultimately enhancing outcomes and supporting value-based care initiatives.

1. CardioANS™ device, an FDA-cleared Class II medical device, is ideal for assessing heart failure (HF) and monitoring arterial hardening, circulation, heart rate variability (HRV), and autonomic nervous system function. 1 eligible billing code.
2. Diabetic Neuropathy Device™ (DND) addresses this gap by being the first FDA-cleared, multi-objective, non-invasive tool that measures both large and small nerve fibers in peripheral extremities. 4 eligible billing codes.
3. TruPAD™ is an FDA Cleared Device that Measures Peripheral Arterial Disease (PAD) at the Point-of-Care. PAD is a condition where the arteries that serve the extremities narrow, reducing blood flow. Over time, this can result in health issues such as heart failure, diabetes, and renal failure, all of which can lead to death depending on the patient's condition. Risk factors for PAD are smoking, diabetes, high blood cholesterol, high blood pressure, heart disease, and stroke. 2 eligible billing codes.

Integrating DTC solutions can boost patient outcomes, streamline workflows, and increase revenue.

Three (3) devices offer five (5) tests and seven (7) eligible billing codes Vs One (1) device offering three (3) tests and three (3) billing codes.

Go Beyond the Ordinary

At DTC, we don’t just provide equipment—we invest in your clinic’s growth. From installation to staff training and beyond, we’re with you every step of the way. Think of us as an extension of your team, dedicated to making your practice thrive.

Primary Care: Comprehensive diabetes assessments and management tools.
Pharmacy: Remote services that are billable by medical providers.
Cardiology: Heart health monitoring and risk assessments.
Endocrinology: Hormonal and metabolic evaluations. :
Neurology: Neuropathy and cognitive assessments.
Podiatry: Diabetic neuropathy foot care and wound management.

These efforts aim to identify and address these conditions early, leading to improved health outcomes and more efficient care delivery. This efficiency ensures that healthcare providers' time and resources are used effectively, enhancing the overall care experience. Go Beyond Diabetes.

2 in 3 of Medicare Patients Have 2 or More Chronic Conditions

Simply Better

Page updated

Report abuse